Solid-phase synthesis of model libraries of 3α,17β-dihydroxy- 16α-(aminoethyl-N-substituted)-5α-androstanes for the development of steroidal therapeutic agents

Molecular Diversity

Volumn 9, Issue 1-3, 2005, Pages 67-79

  Maltais, René ^a   Mercier, Caroline ^a   Labrie, Fernand ^a   Poirier, Donald ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Androstane; Chemical synthesis; Peptide; Solid phase synthesis; Steroid

Indexed keywords

AMINO ACID; ANDROSTANE DERIVATIVE; GLYCINE; ISOLEUCINE; PHENYLALANINE; PROLINE; STEROID;

ARTICLE; BREAST CARCINOMA; CANCER CELL; DRUG ACTIVITY; DRUG SYNTHESIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MODEL; PRIORITY JOURNAL; SOLID; STRUCTURE ACTIVITY RELATION;

ANDROSTANE-3,17-DIOL; ANDROSTANES; ANIMALS; CELL DIVISION; CELL LINE; INDICATORS AND REAGENTS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 15444362511     PISSN: 13811991     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11030-005-1312-z     Document Type: Article

References (28)

1. Hanson, J.R., Steroids: Reactions and partial synthesis, Nat. Prod. Rep., 19 (2002) 381-389, and references therein.
2. Maltais, R., Tremblay, M.R., Ciobanu, L. and Poirier, D., Steroids and combinatorial chemistry, J. Comb. Chem., 6 (2004), 443-456.
3. Poirier, D., Inhibitors of 17β-hydroxysteroid dehydrogenases, Curr. Med. Chem., 10 (2003) 453-477.
4. Singh, S.M., Gauthier, S. and Labrie, F., Androgen receptor antagonist (antiandrogens): Structure-activity relationships, Curr. Med. Chem., 7 (2000) 211-247.
5. Newman, D.J., Cragg, G.M. and Snader, K.M., The influence of natural products upon drug discovery, Nat. Prod. Rep., 17 (2000) 215-234.
6. Bratoeff, E., Ramirez, E., Murillo, E., Flores, G. and Cabeza, M., Steroidal antiandrogens and 5α-reductase inhibitors, Curr. Med. Chem., 6 (1999) 1107-1123.
7. Poirier, D., Ciobanu, L.C. and Maltais, R., Steroid sulfatase inhibitors, Exp. Opin. Ther. Patents., 9 (1999) 1083-1099.
8. Hamada, H., Newmann, F. and Junkman, K., Intrauterine antimaskuline beeinflussing von rattenfetendurch ein stark gestagen wirksames steroid, Steroid Acta Endocrinol., 44 (1963) 330.
9. Labrie, F., Cusan, L., Dupont, A., Gomez, J.L., Simard, J., Luu-The, V., Pelletier, G., Labrie, C. and Bélanger, A., In Reproductive Endocrinology, Surgery and Technology. Lippincott-Raven, Philadelphia, 1996.
10. Brooks, J.R., Berman, C., Primka, R.L., Reynolds, G.F. and Rasmusson, G.H., 5 Alpha-reductase inhibitory and anti-androgenic activities of some 4-azasteroids in the rat, Steroids, 47 (1986) 1-19.
11. Tchédam-Ngatcha, B., Luu-The, V. and Poirier, D., Androsterone 3β-substituted derivatives as inhibitors of type 3 17β-hydroxysteroid dehydrogenase, Bioorg. Med. Chem. Lett., 10 (2000) 2533-2536.
12. Tchédam-Ngatcha, B., Luu-The, V. and Poirier, D., Androsterone derivatives substituted at position 16: Chemical synthesis, inhibition of type 3 17β-hydroxysteroid dehydrogenase, binding affinity for steroid receptors and proliferative/antiproliferative activity on Shionogi (AR+) cells, J. Enz. Inh. Med. Chem., 17 (2002) 155-165.
13. Fevig, T.L. and Katzenellenbogen, J.A., A short, stereoselective route to 16α-(substituted-alkyl)-estradiol derivatives, J. Org. Chem., 52 (1987) 247-251.
14. Tremblay, M.R., Auger, S. and Poirier, D., Synthesis of 16-(bromoalkyl)-estradiols having inhibitory effect on human placental estradiol 17β-hydroxysteroid dehydrogenase (17β-HSD type 1), Bioorg. Med. Chem., 3 (1995) 505-523.
15. Tremblay, M.R. and Poirier, D., Overview of a rational approach to design type I 17β-hydroxysteroid dehydrogenase inhibitors without estrogenic activity: Chemical synthesis and biological evaluation, J. Steroid Biochem. Mol. Biol., 66 (1998) 179-191.
16. Maltais, R., Tremblay, M.R. and Poirier, D., Solid phase synthesis of hydroxysteroids using the diethylsilyloxy linker, J. Comb. Chem., 2 (2000) 604-614.
17. Tremblay, M.R and Poirier, D., Solid-phase of phenolic steroids: From optimization studies to a convenient procedure for combinatorial synthesis of biologically relevant estradiol derivatives, J. Comb. Chem., 2 (2000) 48-65.
18. Hu, Y., Porco, J. A., Labadie, J.W. and Gooding, O.W., Novel polymersupported trialkylsilanes and their use in solid-phase organic synthesis, J. Org. Chem., 63 (1998) 4518-4521.
19. 3-species. Tetrahedron, 46 (1990) 587-594.
20. Furka, A., Sebestyn, F. and Asgedom, M., General method for rapid synthesis of multicomponent peptide mixtures, Int. J. Pept. Protein Res., 37 (1991) 487-493.
21. Smith, P.W., Lai, J.Y.Q., Whittington, A.R., Cox, B., Houston, J.G., Stylli, C.H., Banks, M.N. and Tiller, P.R., Synthesis and biological evaluation of a library containing potentially 1600 amides/esters. A strategy for rapid compound generation and screening, Bioorg. Med. Chem. Lett., 4 (1994) 2821-2824.
22. Pirrung, M.C. and Chen, J., Preparation and screening against acetylcholinesterase of a non-peptide 'indexed' combinatorial library, J. Am. Chem. Soc., 117 (1995) 1240-1245.
23. Sack, J.S., Kish, K.F., Wang, C., Attar, R.M., Kiefer, S.E., An, Y., Wu, G.Y., Scheffler, J.E., Salvati, M.E., Krystek, S.R. Jr., Weinmann, R. and Einspahr, H.M., Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone, Proc. Natl. Acad. Sci. U.S.A., 98 (2001) 4904-4909.
24. Matias, P.M., Donner, P., Coelho, R., Thomaz, M., Peixoto, C., Macedo, S., Otto, N., Joschko, S., Scholz, P., Wegg, A., Bäsler, S., Schäfer, M., Egner, U. and Carrondo, M. A., Structural evidence for ligand specificity in the binding domain of the human androgen receptor. Implications for pathogenic gene mutations, J. Biol. Chem., 275 (2000) 26164-26171.
25. Luthy, I., Begin, D. and Labrie, F., Androgenic activity of synthetic progestins and spironolactone in androgen-sensitive mouse mammary carcinoma (Shionogi) cells in culture, J. Steroid Biochem., 31 (1988) 845-852.
26. Plante, M., Lapointe, S. and Labrie, F., Stimulatory effect of synthetic progestins currently used for the treatment of prostate cancer on growth of the androgen-sensitive Shionogi tumor in mice, J. Steroid Biochem., 31 (1988) 61-64.
27. Simard, J., Dauvois, S., Haagensen, D.E., Lévesque, C., Mérand, Y. and Labrie, F., Regulation of progesterone binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cell: a new marker of steroid action in breast cancer, Endocrinology, 126 (1990) 3223-3231.
28. Fiszer-Szafarz, B., Szafarz, D. and Guevara de Murillo, A., A general, fast and sensitive micromethod for DNA determination: Application to rat and mouse liver, rat hepatoma, human leukocytes, chicken fibroblasts and yeast cells, Anal. Biochem., 110 (1981) 165-170.